Increased Survivorship and Altered Cytokine Profile from Treatment of Influenza A H1N1-Infected Mice with Ekybion: A Drug Complex of Natural Extracts and Inorganic Compounds

Table 2

Survivorship for Balb/c mice treated with Ekybion.

Treatment start	Administration time (Ekybion conc.)	Survivorship live/total	Mean day of death ± SD	Log rank test
3 hour pre	2 min (control)	0/13	9.23±2.13
3 hour pre	2 min (1X)	6/13	9.86±1.77	𝑃=.0078
3 hour pre	4 min (1X)	0/6	10.0±1.67
3 hour pre	2 min (10X)	1/6	9.20±1.10
6 hour post	2 min (1X)	0/7	9.43±2.37

Eight-week-old female Balb/c mice were infected with 5 MLD₅₀ of influenza A/PR/8/34 H1N1 and treated three times daily for 10 days.